Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver Disease
酒精相关性肝病患者肝移植候选者的选择
基本信息
- 批准号:10660978
- 负责人:
- 金额:$ 19.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAcuteAcute Alcoholic HepatitisAdrenal Cortex HormonesAlcohol consumptionAlcoholic HepatitisAlcoholic Liver DiseasesAlcoholsAttenuatedBehavioralBiological MarkersBiometryCessation of lifeChronicCirrhosisClinical InvestigatorCohort StudiesCollaborationsCommunitiesConsensusCountryDataDecision MakingDelphi TechniqueDevelopmentDevelopment PlansElectronicsEuropeEvaluationEventFosteringFundingFutureGoalsGraft RejectionHepatitis CHepatologyInferiorInjuryInterventionInterviewKnowledgeLiver diseasesMedicalMedicineMulticenter TrialsNational Institute on Alcohol Abuse and AlcoholismNatural HistoryOutcomePatientsPilot ProjectsPredictive AnalyticsProcessProgram DevelopmentProtocols documentationQuestionnairesRefractoryRelapseReproducibilityResearchResearch PersonnelResearch TrainingRisk EstimateScienceScientistSelection CriteriaSocial supportStandardizationSurveysTransplant RecipientsTransplantationUnited StatesUniversitiesValidationWorkaddictionadverse outcomealcohol abstinencealcohol abuse therapyalcohol relapsealcohol researchalcohol screeningcandidate selectioncareer developmentcohortempowermentevidence baseexperiencefollow-upimprovedinterdisciplinary approachliver transplantationmembermortalitymortality risknon-alcoholic fatty liver diseasenovelpost-transplantpredictive modelingprolonged abstinencerelapse riskrisk predictionskillssobrietysubstance usesupportive environmenttooltransplant centers
项目摘要
PROJECT SUMMARY
Alcohol consumption is a major cause of liver disease worldwide. Severe alcoholic hepatitis (SAH), an acute
manifestation of alcohol-related liver disease (ALD), is associated with inferior short-term survival. Unfortunately,
there are few effective medical therapies for SAH outside of corticosteroids, to which about 40% of patients are
refractory. For these patients, liver transplantation (LT) is the only rescue treatment available. Until recently,
most transplant centers mandated at least six months of continuous abstinence from alcohol before LT.
Unfortunately, this “6-month rule” was(is) often unachievable for patients with SAH, due to recent alcohol use
and high short-term mortality. Several recent studies from Europe and the United States championed the concept
of early liver transplantation (ELT) in this highly vulnerable patient cohort, though post-LT alcohol relapse
remained a concern with adverse consequences like graft injury and cirrhosis.
To date, there is no consensus on the optimal LT candidate selection criteria in ALD, which can lead to uneven
and substandard post-LT outcomes, including alcohol relapse. This project will advance our field in several ways.
First, it will define the impacts of ELT and alcohol abstinence on the natural history of SAH. Second, it will develop
and validate a novel LT candidate selection tool in ALD. The project findings will support a planned multicenter
trial and R01 submission for the external evaluation of the candidate selection tool.
This proposed work represents an interdisciplinary approach toward the optimization and the standardization of
the LT candidate selection process in ALD. To conduct this study, I will integrate myself into the research
community of the NIAAA P50-funded Johns Hopkins DELTA Center for Alcohol Research, which will help me
establish a network of alcohol researchers for current and future collaboration. I will also actively engage in
formal coursework in biostatistics and addiction science as well as interdisciplinary career development
programs. Through the proposed career development plan, I will gain the necessary skills and experience to
establish myself as an independent clinical investigator bridging the fields of hepatology, transplantation, and
addiction medicine.
项目总结
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Liver Transplant in Hemoglobin SC Disease and Autoimmune Hepatitis: A Case Report.
- DOI:10.6002/ect.2021.0350
- 发表时间:2022-04
- 期刊:
- 影响因子:0.9
- 作者:Kim, Ahyoung;Assarzadegan, Naziheh;Anders, Robert A.;Oshima, Kiyoko;Chaturvedi, Shruti;Weeks, Sharon;Kohli, Ruhail;Lanzkron, Sophie;Gurakar, Ahmet;Garonzik-Wang, Jacqueline;Chen, Po-Hung
- 通讯作者:Chen, Po-Hung
Two Acute Liver Injuries in a Patient With Malnutrition.
- DOI:10.14740/jmc3713
- 发表时间:2021-08
- 期刊:
- 影响因子:0
- 作者:Su A;Choe M;Birkness JE;Limketkai B;Chen PH
- 通讯作者:Chen PH
Clinical Considerations of Coagulopathy in Acute Liver Failure.
- DOI:10.14218/jcth.2020.00058
- 发表时间:2020-12-28
- 期刊:
- 影响因子:3.6
- 作者:Kim A;Niu B;Woreta T;Chen PH
- 通讯作者:Chen PH
Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group.
- DOI:10.1016/j.cgh.2020.10.026
- 发表时间:2021-11
- 期刊:
- 影响因子:0
- 作者:Im GY;Mellinger JL;Winters A;Aby ES;Lominadze Z;Rice J;Lucey MR;Arab JP;Goel A;Jophlin LL;Sherman CB;Parker R;Chen PH;Devuni D;Sidhu S;Dunn W;Szabo G;Singal AK;Shah VH
- 通讯作者:Shah VH
Burden of Crohn's Disease in the United States Medicaid Population, 2010-2019.
2010-2019 年美国医疗补助人群的克罗恩病负担。
- DOI:10.1016/j.cgh.2023.05.002
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Hutfless,Susan;Jasper,RyanA;Chen,Po-Hung;Joseph,Shelly;Miller,Steve;Brant,StevenR
- 通讯作者:Brant,StevenR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Po-Hung (Victor) Chen其他文献
Po-Hung (Victor) Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Po-Hung (Victor) Chen', 18)}}的其他基金
Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver Disease
酒精相关性肝病患者肝移植候选者的选择
- 批准号:
10166736 - 财政年份:2020
- 资助金额:
$ 19.82万 - 项目类别:
Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver Disease
酒精相关性肝病患者肝移植候选者的选择
- 批准号:
10451532 - 财政年份:2020
- 资助金额:
$ 19.82万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 19.82万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 19.82万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 19.82万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 19.82万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 19.82万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 19.82万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 19.82万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 19.82万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 19.82万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 19.82万 - 项目类别:
Standard Grant